Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-25-006585
Filing Date
2025-11-12
Accepted
2025-11-12 13:09:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11724
2 d12036868_ex99-a.htm EX-99 6260
  Complete submission text file 0000919574-25-006585.txt   19875
Mailing Address 152 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 50TH FLOOR NEW YORK NY 10019 212-333-0100
KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by) CIK: 0001000097 (see all company filings)

EIN.: 134015739 | State of Incorp.: DE
Type: SCHEDULE 13G/A

Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Subject) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88127 | Film No.: 251471288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)